Form 4: Ardelyx CFO Executes Sell-to-Cover Transaction

Ardelyx CFO Susan Hohenleitner sold 1,455 shares of common stock to satisfy tax withholding obligations related to RSU vesting.

Summary

• Susan Hohenleitner, Chief Financial Officer of Ardelyx, Inc., sold 1,455 shares of common stock.
• The transaction occurred on May 21, 2026, at a price of $6.2675 per share.
• Following this transaction, the reporting person maintains beneficial ownership of 229,078 shares.
• The sale was conducted automatically to cover tax withholding requirements upon the vesting of restricted stock units (RSUs).

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the sale was purely administrative and required to satisfy tax obligations.

Positives

• The transaction was a mandatory sell-to-cover event rather than a discretionary sale, indicating no change in management sentiment regarding the company's long-term prospects.

Negatives

• Reduction in direct share ownership by a key executive.

Risks

• General market volatility affecting the share price of Ardelyx, Inc. (ARDX).

Future Outlook

No forward-looking guidance or strategic outlook was provided in this regulatory filing.

Industry Context

StockSavvy.ai notes that sell-to-cover transactions are standard administrative procedures for executives receiving equity-based compensation and do not typically signal a change in corporate strategy or executive confidence.

Comparison to Industry Standards

• The transaction aligns with standard corporate governance practices for handling tax obligations on vested equity awards in the biotechnology sector.

Stakeholder Impact

• Minimal impact on shareholders as the transaction was a routine tax-related sell-to-cover.

Key Dates

Keywords

ARDX, Ardelyx, Insider Trading, Form 4, CFO, Equity Compensation